Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
349.94
-0.56 (-0.16%)
At close: Oct 6, 2025, 4:00 PM EDT
349.94
0.00 (0.00%)
Pre-market: Oct 7, 2025, 8:02 AM EDT
Elevance Health Revenue
Elevance Health had revenue of $49.78B in the quarter ending June 30, 2025, with 14.04% growth. This brings the company's revenue in the last twelve months to $189.25B, up 10.21% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$189.25B
Revenue Growth
+10.21%
P/S Ratio
0.42
Revenue / Employee
$1,816,257
Employees
104,200
Market Cap
78.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ELV News
- 3 days ago - Many Large U.S. Insurers Trade In The Green As Shutdown Continues - Seeking Alpha
- 7 days ago - Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2025 Results on October 21 - Business Wire
- 11 days ago - Elevance Health: Undervalued Defensive Giant With Long-Term Upside - Seeking Alpha
- 13 days ago - Northwest Middle School Unveils New Weight Room in Partnership with Elevance Health and Impact Fitness Foundation - Business Wire
- 26 days ago - AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Notes - Business Wire
- 4 weeks ago - Elevance Health: Keep It Simple And Buy This Great Business At A Low Valuation - Seeking Alpha
- 4 weeks ago - Elevance Health Foundation Awards $6.5 Million to Strengthen Maternal and Infant Health Across the United States - Business Wire
- 5 weeks ago - Top 15 High-Growth Dividend Stocks For September 2025 - Seeking Alpha